Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
about
Metorphamide: isolation, structure, and biologic activity of an amidated opioid octapeptide from bovine brainPharmacology of nociceptin and its receptor: a novel therapeutic targetDynorphin--still an extraordinarily potent opioid peptideLong-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in miceMolecular dynamics simulations predict a tilted orientation for the helical region of dynorphin A(1-17) in dimyristoylphosphatidylcholine bilayers.Evidence for a selective processing of proenkephalin B into different opioid peptide forms in particular regions of rat brain and pituitary.Dynorphin is expressed primarily by GABAergic neurons that contain galanin in the rat dorsal horn.Opioid peptides and primary biliary cirrhosis.Evidence that the agonist action of dynorphin A(1-8) in the guinea-pig myenteric-plexus may be mediated partly through conversion to [Leu5]enkephalin.Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptorDelta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.Synaptic localization of kappa opioid receptors in guinea pig neostriatum.Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cordDynorphin and the pathophysiology of drug addiction.Kappa-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate.Proenkephalin, [Met]enkephalin, and oxytocin immunoreactivities are colocalized in bovine hypothalamic magnocellular neurons.Immunohistochemical distribution of dynorphin B in rat brain: relation to dynorphin A and alpha-neo-endorphin systems.Mu and kappa opioids inhibit transmitter release by different mechanisms.Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Hypocretin/Orexin and Plastic Adaptations Associated with Drug Abuse.Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.Peptide neuroregulators: the opioid system as a model.The many possible roles of opioids and related peptides in stress-induced analgesia.Plasma beta endorphin in cirrhosis and renal failure.kappa-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat.Exposure to cocaine alters dynorphin-mediated regulation of excitatory synaptic transmission in nucleus accumbens neurons.Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum.Is ascites caused by impaired hepatic inactivation of blood borne endogenous opioid peptides?Interaction between the cardiovascular effects of clonidine and the kappa-opioid agonist U-50,488H in the anterior hypothalamic area of the rat brain.Influence of intrastriatal infusion of dynorphin fragments on overflow of acetylcholine and dopamine in the rat brain.An inhibitor of endopeptidase-24.15 blocks the degradation of intraventricularly administered dynorphins.Relationship between primary structure and activity in exorphins and endogenous opioid peptides.Focal stimulation of the mossy fibers releases endogenous dynorphins that bind kappa 1-opioid receptors in guinea pig hippocampus.Isolation and characterization of opioid peptides from rabbit cerebellum.Characterization of opioid binding sites in the neural and intermediate lobe of the rat pituitary gland by quantitative receptor autoradiography.Autoradiographic visualization of kappa opioid receptors with labelled dynorphins in guinea pig brain.Enhanced Neurohypophyseal Vasopressin Release is Associated with Increased Opioid Inhibition of Oxytocin Release.Intrahypothalamic Mu-, not Delta- or Kappa-Opioid Receptor Activation Causes Growth Hormone Secretion.Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide.
P2860
Q24614482-CA20E748-02C7-469B-980D-04CDE9032E89Q24675084-906D4712-2C25-410A-9ABB-C6BF604F1701Q26860519-3279DEC0-782D-42ED-93AF-191040A019BCQ28363126-43186360-4B8A-49F5-8384-7783777030D9Q30618753-7ACB0339-7CFA-41BE-8DCC-5400DDE62325Q34247866-578B7730-67B6-42FE-959C-630B54C5B551Q35338374-0B4C9C0F-44E8-43BD-B89D-6E35689461F0Q35706319-91AB8428-6CB4-48F9-A166-C7C25511ED70Q35888409-4A361C14-0789-4261-8028-8687881821A8Q36004219-BF08F18D-37A0-4002-AA47-156ADD4394C4Q36437547-106A5614-6685-4089-824F-2E56AE9CD726Q36787784-9D038DCB-F710-4C53-ACD6-117982FD22A0Q36917570-E0B40585-EF39-4E4D-AB81-02655B63CADBQ36942175-51125A08-668C-460E-B311-9D53AF8BD24FQ37130532-D1C87109-5BD8-4EA9-9DE9-8521CEAB0A11Q37346660-BA2D4D0D-AE3B-45C6-A532-4CC1602292DAQ37604325-6B284C48-547B-484A-B676-198AB538E28CQ37681064-D311E853-7AEC-4958-94E9-982DA91B44B1Q37691150-D2330024-C2BC-416C-967A-CE787E3F9D0DQ38217456-E1DFC3CD-AA7D-47B7-8F89-20B536EA6BEDQ39183160-E7ABC6C3-F299-4895-BD93-E2513FA212D7Q39361359-D084AD45-9F1C-4499-842B-96865C97B4A8Q39478053-4A48F6F3-B4DA-47E5-85B0-C5EAE02B80CBQ39479086-3135E268-CF84-4892-8AC0-9E87ECA5BFEDQ41181523-89E2E65A-AE60-46C1-B0BE-AA96B9C95B47Q41775466-EE879233-639E-4ACB-99E9-BABF5850BD1EQ41821021-E299DAFF-9024-47DC-9CB4-9462B81488F2Q41922304-4B5E3A7F-F9B6-4DA0-A4A6-E43806D6136EQ42123454-E9F6AE72-587F-41CA-9DC2-B340D4ED44FFQ42190149-BC39383F-71A0-404E-A641-51C28ED2B532Q43239586-C2EF5B4C-5133-47C0-AB18-9817C9067F05Q44115274-7B7502A5-D53C-4782-8783-5D4D9BFC8807Q44333326-F359629B-A24B-4330-B090-C11B9EA57F50Q44335147-654F1E14-4AF4-47DA-A96E-F8B53071A146Q44337222-EDEBCC9D-49DF-4D92-BCBD-676621881A84Q44337506-CEE9A8C2-0229-46C5-81D9-EF93A260B0DDQ44341017-90AEC029-8E57-4DC8-9632-026E083770E9Q44341542-667030AE-D66F-456C-AADC-8E0CB9DB962EQ44341557-42CB2137-7F13-48C7-94FA-F88A7BC19776Q44342839-79439376-EF3F-4F2A-909D-FAA1D2F75FF2
P2860
Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh-hant
name
Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
@en
Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
@nl
type
label
Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
@en
Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
@nl
prefLabel
Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
@en
Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
@nl
P2093
P356
P1433
P1476
Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
@en
P2093
Corbett AD
Kosterlitz HW
McKnight AT
Paterson SJ
P2860
P2888
P356
10.1038/299079A0
P407
P577
1982-09-01T00:00:00Z
P6179
1041044746